月度归档： 2026 年 8 月

August 2026, Rome: Soil degradation is continuing to worsen in many parts of the world, while proven practices to protec…

CropX has continued its buying spree with the acquisition of near-infrared spectroscopy specialist SCIO and says it is n…

By Editor, Global AgInvesting MediaComputomics GmbH, a bio-analytics and genomic prediction company headquartered in Tübingen, Germany, has completed a €6.3 million Series B funding round, according to a recent press release. The investment round was led by Convent Capital Agri Food Fund with a €5 million contribution, alongside participation from existing backers including High-Tech Gründerfonds (HTGF), MBG Baden-Württemberg, Amathaon Capital, as well as the company’s founders and scientific advisors.The financing is backed by support from the European Union’s InvestEU Fund.

Why it matters: The financing is part of Redx’s efforts to secure the funding needed to show whether its gut-restricted drug candidate, RXC008, works. By tackling fibrosis rather than focusing on inflammation, the therapy could provide fibrostenotic Crohn’s patients with an alternative to surgical intervention.

August 2026, Rome: Restoring rangelands and desert landscapes is central to food security, livelihoods and resilient rur…

Quadpack has launched the Mahina Tottle for low-viscosity, precise dosing skin care applications. The tottle — a combination of a tube and bottle — is equipped with a cold-touch, roll-on metal applicator that offers a sensory user experience. Quadpack says the applicator is also mess-free due to an on/off locking system. 

By Editor, Global AgInvesting MediaAn investment offering for the Ventura Valley Avocado Grove, an 81-gross-acre permanent crop ranch in Moorpark, California, is currently open to accredited investors on FarmTogether. Located in the heart of Ventura County, the deal highlights how institutional farmland managers evaluate near-term crop yields against long-term property redevelopment in premier growing regions.

A landmark study published this week in Science could help scientists answer some fundamental questions about the genetic basis of autism spectrum disorder including how mutations in ASD risk genes lead directly to changes in brain development, and how that knowledge can be translated into more effective therapies.

Why it matters: The Ebola epidemic in the Democratic Republic of the Congo is becoming a stress test for global vaccine preparedness. The outbreak is not being caused by Zaire Ebola virus, for which the approved vaccine Ervebo is already available, but by the much rarer Bundibugyo Ebola virus. There is currently neither an approved vaccine nor a specific treatment for this virus. At the same time, case numbers in the DR Congo continue to rise exponentially.